{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fan T"],"funding":["National Key R&D Program of China","CAMS Innovation Fund for Medical Sciences (CIFMS)","National Key R&D Program of China","CAMS Innovation Fund for Medical Sciences","National Natural Science Foundation of China"],"pagination":["122"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10155324"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(1)"],"pubmed_abstract":["Backgroud
The role of epigenetic modifications in tumorigenesis has been widely reported. However, the role and mechanism of H3K4me3 modification in lung adenocarcinoma (LUAD) are rarely reported systematically. We, therefore, sought to analyze the characteristics of LUAD associated with H3K4me3 modification, build an H3K4me3-lncRNAs score model to predict the prognosis of patients with LUAD and clarify the potential value of H3K4me3 in immunotherapy of LUAD.Methods
We evaluated H3K4me3-lncRNA patterns and H3K4me3-lncRNA scores of 477 LUAD samples based on 53 lncRNAs closely correlated to H3K4me3 regulators and comprehensive analyzed the role of these patterns in tumorigenesis and tumor immunity. Using Gene set variation analysis (GSVA), we systematically evaluated the H3K4"],"journal":["Respiratory research"],"pubmed_title":["H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma."],"pmcid":["PMC10155324"],"funding_grant_id":["2021-1-I2M-012","81972196","2021YFF1201300, 2020AAA0109505, YS2021YFF120009"],"pubmed_authors":["Zhu M","Liu Y","Li S","Li C","Muhammad S","He J","Tian H","Zheng B","Xue L","Xiao C","Fan T"],"additional_accession":[]},"is_claimable":false,"name":"H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.","description":"Backgroud
The role of epigenetic modifications in tumorigenesis has been widely reported. However, the role and mechanism of H3K4me3 modification in lung adenocarcinoma (LUAD) are rarely reported systematically. We, therefore, sought to analyze the characteristics of LUAD associated with H3K4me3 modification, build an H3K4me3-lncRNAs score model to predict the prognosis of patients with LUAD and clarify the potential value of H3K4me3 in immunotherapy of LUAD.Methods
We evaluated H3K4me3-lncRNA patterns and H3K4me3-lncRNA scores of 477 LUAD samples based on 53 lncRNAs closely correlated to H3K4me3 regulators and comprehensive analyzed the role of these patterns in tumorigenesis and tumor immunity. Using Gene set variation analysis (GSVA), we systematically evaluated the H3K4","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-22T04:03:03.407Z","creation":"2025-04-05T20:51:26.228Z"},"accession":"S-EPMC10155324","cross_references":{"pubmed":["37131252"],"doi":["10.1186/s12931-023-02418-1"]}}